12:00 AM
 | 
Oct 06, 2008
 |  BC Week In Review  |  Company News  |  Other News

PharmAthene, National Institutes of Health infectious news

PharmAthene received a three-year, $13.2 million contract from the NIH's National Institute of Allergy and Infectious Disease (NIAID) to develop a...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >